Empagliflozin (EMPA) Compared with Glimepiride (GLIM) as Add-On to Metformin (MET) for 2 Years in Patients with Type 2 Diabetes (T2DM)
Ridderstråle, Martin, Andersen, Knut Robert, Zeller, Cordula, Kim, Gabriel, Woerle, Hans J., Broedl, UliVolume:
38
Language:
english
Journal:
Canadian Journal of Diabetes
DOI:
10.1016/j.jcjd.2014.07.156
Date:
October, 2014
File:
PDF, 51 KB
english, 2014